ADD CONDITION

items per page

Reinreude Tag Wart

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Salicylic Acid 40 g/100 1
Other brand names
Dosage form
Patch
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2024
Label revision date
November 20, 2025
Active ingredient
Salicylic Acid 40 g/100 1
Other brand names
Dosage form
Patch
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2024
Label revision date
November 20, 2025
Manufacturer
Jiangxi Hemei Pharmaceutical Co. , Ltd
Registration number
M028
NDC root
84010-054

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

This medication is used for the removal of warts and corns, which are common skin growths that can be bothersome. It works by targeting these growths to help eliminate them, providing relief and improving the appearance of your skin. If you're dealing with warts or corns, this treatment may be a suitable option to consider for effective removal.

Uses

You can use this medication to help remove warts and corns from your skin. Warts are small growths caused by a virus, while corns are thickened areas of skin that often develop on your feet due to pressure or friction.

It's important to note that this medication does not have any known effects that could harm a developing fetus (teratogenic effects) or cause other nonteratogenic effects. Always consult with your healthcare provider if you have any questions or concerns about using this treatment.

Dosage and Administration

To start treating your wart, first wash the affected area thoroughly. You may also choose to soak the wart in warm water for about 5 minutes to help soften it, but make sure to dry the area completely afterward. If the medicated plaster doesn’t fit the wart perfectly, you can cut it to size.

Once you have the plaster ready, apply it directly to the wart. For the best results, repeat this process every 48 hours as needed, but do not continue for more than 12 weeks. This routine will help you effectively manage the wart over time.

What to Avoid

It's important to use this product safely to avoid potential complications. You should not use it on irritated, infected, or reddened skin, as well as on genital warts, facial warts, moles, birthmarks, or any warts with hair growing from them. Additionally, avoid applying it to mucous membranes, which are the moist tissues lining certain body parts.

Be cautious to prevent contact with your eyes or face. If the product accidentally gets into your eyes, rinse them thoroughly with water to minimize irritation. Following these guidelines will help ensure your safety while using the product.

Side Effects

It's important to note that this product is for external use only. If you experience any discomfort that continues, you should stop using it. Additionally, if you have diabetes or poor blood circulation, it's a good idea to consult with your doctor before using this product to ensure it's safe for you.

Warnings and Precautions

This product is for external use only. If you accidentally swallow it, seek medical help or contact a Poison Control Center immediately. It's important not to apply this product to irritated, infected, or reddened skin, as well as on genital warts, facial warts, moles, birthmarks, or any warts with hair growing from them. Additionally, avoid using it on mucous membranes (the moist tissue lining certain body cavities).

If you experience ongoing discomfort after using the product, stop using it and call your doctor. Be cautious to keep the product away from your eyes and face; if it does get into your eyes, rinse them thoroughly with water. If you have diabetes or poor blood circulation, consult your doctor before using this product.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's important to be aware of the general signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect an overdose, it is crucial to seek immediate medical help.

In case of an emergency, call your local emergency services or go to the nearest hospital. Always keep medications out of reach of children and follow the prescribed dosage to prevent any potential risks. If you have any concerns or questions about your medication, don’t hesitate to reach out to your healthcare provider for guidance.

Pregnancy Use

When it comes to using this medication during pregnancy, there is currently no information available regarding its safety, recommended dosage adjustments, or any special precautions you should take. This means that if you are pregnant or planning to become pregnant, it is essential to consult with your healthcare provider before starting or continuing this medication. They can help you weigh the potential risks and benefits based on your individual situation. Always prioritize open communication with your doctor to ensure the best care for you and your baby.

Lactation Use

Currently, there is no specific information available about the use of REINREUDE TAG WART, which contains salicylic acid 40%, for nursing mothers or during lactation (the period when a mother breastfeeds her baby). This means that it’s unclear how this product may affect you or your breastfeeding infant.

If you are considering using this product while breastfeeding, it’s a good idea to consult with your healthcare provider to discuss any potential risks or concerns. They can help you make an informed decision that prioritizes your health and the well-being of your baby.

Pediatric Use

It's important to keep this medication out of reach of children to prevent accidental ingestion. If your child swallows any of it, seek medical help immediately or contact a Poison Control Center for guidance. Taking these precautions can help ensure your child's safety.

Geriatric Use

While there is no specific information about how this medication should be used by older adults, it’s important to approach any new treatment with caution. Since older adults may have different health needs and may be taking multiple medications, it’s always a good idea to discuss any new prescriptions with your healthcare provider. They can help ensure that the medication is safe and appropriate for you or your loved one, considering any existing health conditions or medications.

If you have concerns about how this medication might affect you or an older adult in your care, don’t hesitate to ask your doctor or pharmacist for more information. They can provide guidance tailored to individual health situations.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment is safe and effective for your specific health needs. They can help determine the best approach for managing your condition while considering your kidney health.

Hepatic Impairment

If you have liver problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or precautions related to your condition. This means that there are no tailored recommendations for how the medication may need to be adjusted or monitored based on your liver function.

Always consult your healthcare provider for personalized advice and to ensure that any treatment plan is safe and effective for you, especially if you have a history of liver issues. Your doctor can help determine the best approach based on your individual health needs.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you. Always share your complete list of medications and any recent lab tests to avoid any potential issues. Your health and safety should always come first.

Storage and Handling

To ensure the best performance of your product, store it in a cool, dry place at temperatures between 59°F and 86°F (15°C and 30°C). This temperature range helps maintain the product's effectiveness and safety.

When handling the product, be sure to keep it in a clean environment to avoid contamination. Always follow any specific instructions provided for use and disposal to ensure safety and effectiveness.

Additional Information

No further information is available.

FAQ

What is this drug used for?

This drug is used for the removal of warts and corns.

Are there any teratogenic effects associated with this drug?

No teratogenic effects are mentioned for this drug.

What should I do before applying the medicated plaster?

You should wash the affected area and optionally soak the wart in warm water for 5 minutes, then dry the area thoroughly.

How often should I apply the medicated plaster?

You should repeat the application every 48 hours as needed, for up to 12 weeks.

Where should I not use this drug?

Do not use it on irritated, infected, or reddened skin; genital warts; warts on the face; moles; birthmarks; warts with hair; or mucous membranes.

What should I do if I experience discomfort?

You should stop use if discomfort persists.

What precautions should I take regarding eye contact?

Avoid contact with eyes or face. If the product gets into your eyes, rinse thoroughly with water.

What should I do if the product is swallowed?

Get medical help or contact a Poison Control Center right away.

Is this drug safe for children?

Keep this drug out of reach of children.

What should I do if I have diabetes or poor blood circulation?

Ask a doctor before using this drug if you have diabetes or poor blood circulation.

What is the recommended storage temperature for this drug?

Store the drug between 59°F and 86°F (15°C and 30°C).

Packaging Info

Below are the non-prescription pack sizes of Reinreude Tag Wart (salicylic acid 40% tag wart). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Reinreude Tag Wart.
Details

Drug Information (PDF)

This file contains official product information for Reinreude Tag Wart, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of warts and corns.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

The affected area should be washed thoroughly prior to application. Optionally, the wart may be soaked in warm water for 5 minutes to facilitate treatment; after soaking, the area must be dried thoroughly. If necessary, the medicated plaster can be cut to fit the size of the wart.

The medicated plaster should be applied directly to the wart. This process may be repeated every 48 hours as needed, with a maximum duration of treatment not exceeding 12 weeks.

Contraindications

Use of this product is contraindicated on irritated, infected, or reddened skin. It should not be applied to genital warts, facial warts, moles, birthmarks, or warts with hair growing from them, as well as on mucous membranes.

Additionally, contact with the eyes or face must be avoided. In the event of accidental exposure to the eyes, it is imperative to rinse thoroughly with water.

Warnings and Precautions

This product is intended for external use only. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

The product must not be applied to irritated, infected, or reddened skin. It is contraindicated for use on genital warts, facial warts, moles, birthmarks, or any warts with hair growing from them. Additionally, application on mucous membranes is prohibited. Should any discomfort persist following use, the application should be discontinued.

Care should be taken to avoid contact with the eyes or face. In the event that the product comes into contact with the eyes, it is imperative to rinse thoroughly with water.

Healthcare professionals should inquire about the patient's medical history, particularly regarding diabetes or poor blood circulation, prior to recommending this product.

Side Effects

For external use only. Patients should discontinue use if discomfort persists. It is advised that individuals with diabetes or poor blood circulation consult a doctor prior to use.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Reinreude Tag Wart (salicylic acid 40% tag wart). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Reinreude Tag Wart.
Details

Pediatric Use

Pediatric patients should be advised to keep the medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or any special precautions that should be taken. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients and weigh the potential risks and benefits. Women of childbearing potential should be counseled on the absence of information related to pregnancy and advised to discuss any concerns with their healthcare provider.

Lactation

There is no information available regarding the use of REINREUDE TAG WART - salicylic acid 40% tag wart patch in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider this lack of data when advising lactating mothers on the use of this product.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may arise from an overdose. Common symptoms may include, but are not limited to, severe drowsiness, confusion, respiratory distress, or any unusual physiological changes.

Management of an overdose should be tailored to the individual patient and may involve supportive care, including monitoring vital signs and providing symptomatic treatment as necessary. In cases of significant overdose, consultation with a poison control center or toxicology specialist is recommended to determine the most appropriate course of action.

It is crucial for healthcare professionals to educate patients about the importance of adhering to prescribed dosages and to provide guidance on what to do in the event of a suspected overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that the product should not be applied to irritated, infected, or reddened skin, nor should it be used on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Additionally, patients should be instructed to avoid using the product on mucous membranes.

Healthcare providers should counsel patients to discontinue use if discomfort persists and to avoid contact with the eyes or face. In the event that the product comes into contact with the eyes, patients should rinse thoroughly with water. Furthermore, patients with diabetes or poor blood circulation should be encouraged to consult their doctor before using the product.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within a temperature range of 59°F to 86°F (15°C to 30°C) to maintain its efficacy and integrity. Proper container requirements should be adhered to, ensuring that the product is kept in a suitable environment. Special handling needs must be observed to prevent any compromise to the product's quality during storage and transportation.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Reinreude Tag Wart, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Reinreude Tag Wart, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.